Aller au contenu principal
Profil bibliographique

Michelle L. Wiese

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

14Publications signalées
167Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Immunotherapy and Immune ResponsesImmune cells in cancerNanoplatforms for cancer theranosticsCancer Immunotherapy and BiomarkersAnesthesia and Pain Management

Les publications récentes

Accès ouvert 2024 article OpenAlex

Uso de redes sociais por cirurgiões com treinamento especializado em trauma ortopédico

Haley E. Smith, Colin K. Cantrell, Cody Goedderz, Michelle L. Wiese et autres

Resumo Objetivo: Quantificar o uso de plataformas de rede social por traumato-ortopedistas, com ênfase nas diferenças demográficas, regionais e de tipo de prática clínica. Materiais e Métodos: Utilizando o banco de dados de membros da Orthopaedic Trauma Association (OTA), foram realizadas pesquisas …

us (code pays fourni par la source)

0 citations Revista Brasileira de Ortopedia
Accès ouvert 2024 article OpenAlex

Postpartum Psychosis: A Preventable Psychiatric Emergency

Ramanpreet Toor, Michelle L. Wiese, Carmen Croicu, Amritha Bhat

Postpartum psychosis is the most severe psychiatric disorder associated with childbirth. Although rare, it is considered a psychiatric emergency that warrants immediate medical attention and inpatient care to ensure safety, complete diagnostic evaluation, and treatment initiation. This article describes the phenomenology of …

us (code pays fourni par la source)

5 citations FOCUS The Journal of Lifelong Learning in Psychiatry
Accès ouvert 2023 article OpenAlex

New-Onset Paralysis following Biopsy of a Retroperitoneal Mass with Intraspinal Extension in a Pediatric Patient

Michelle L. Wiese, Shankar Rajeswaran

Image-guided percutaneous biopsies are routine, safe procedures and complications are infrequent and usually directly related to the biopsy itself. This report describes a biopsy of a retroperitoneal mass with extension into the spinal canal, following which the patient developed paralysis unrelated to …

us (code pays fourni par la source)

1 citation Seminars in Interventional Radiology
Accès ouvert 2023 other OpenAlex

Data from Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity

Prabhani U. Atukorale, Shruti Raghunathan, Vanitha Raguveer, Taylor J. Moon et autres

Abstract Effective cancer immunotherapy depends on the robust activation of tumor-specific antigen-presenting cells (APC). Immune agonists encapsulated within nanoparticles (NP) can be delivered to tumor sites to generate powerful antitumor immune responses with minimal off-target dissemination. Systemic delivery enables widespread access to …

0 citations
Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Data from Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity

Prabhani U. Atukorale, Shruti Raghunathan, Vanitha Raguveer, Taylor J. Moon et autres

SF1: IFNβ production from macrophages by ELISA analysis; SF2: FMT imaging of mammary tumors ex vivo for spatial localization of nanoparticle; SF3: Confocal micrographs of DiI-nanoparticle fluorescence in mammary tumor tissue; SF4: Representative images of tumor masses 4 days post-treatment; SF5: Primary …

us (code pays fourni par la source)

0 citations
Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Data from Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity

Prabhani U. Atukorale, Shruti Raghunathan, Vanitha Raguveer, Taylor J. Moon et autres

SF1: IFNβ production from macrophages by ELISA analysis; SF2: FMT imaging of mammary tumors ex vivo for spatial localization of nanoparticle; SF3: Confocal micrographs of DiI-nanoparticle fluorescence in mammary tumor tissue; SF4: Representative images of tumor masses 4 days post-treatment; SF5: Primary …

us (code pays fourni par la source)

0 citations
Accès ouvert 2023 other OpenAlex

Data from Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity

Prabhani U. Atukorale, Shruti Raghunathan, Vanitha Raguveer, Taylor J. Moon et autres

Abstract Effective cancer immunotherapy depends on the robust activation of tumor-specific antigen-presenting cells (APC). Immune agonists encapsulated within nanoparticles (NP) can be delivered to tumor sites to generate powerful antitumor immune responses with minimal off-target dissemination. Systemic delivery enables widespread access to …

0 citations
Accès ouvert 2021 article OpenAlex

Comparison of the uptake of untargeted and targeted immunostimulatory nanoparticles by immune cells in the microenvironment of metastatic breast cancer

Gil Covarrubias, Taylor J. Moon, Georgia Loutrianakis, Haley M. Sims et autres

integrin and P-selectin that are commonly used to direct nanoparticles to tumors. Using the 4T1 mouse model, we assessed the microdistribution of the four NP variants in the tumor immune microenvironment in three different breast cancer landscapes, including primary tumor, early metastasis, …

us (code pays fourni par la source)

18 citations Journal of Materials Chemistry B
Accès ouvert 2020 article OpenAlex

Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors

Peter A. Bielecki, Morgan E. Lorkowski, Wyatt M. Becicka, Prabhani U. Atukorale et autres

T cell activity (2.5-fold) and delayed GBM tumor growth. We show that an engineered immunostimulatory nanoparticle can support pro-inflammatory innate immune function in GBM and subsequently augment current immunotherapeutic interventions and improve their therapeutic outcome.

us (code pays fourni par la source)

56 citations Nanoscale Horizons
Accès ouvert 2019 article OpenAlex

Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity

Prabhani U. Atukorale, Shruti Raghunathan, Vanitha Raguveer, Taylor J. Moon et autres

Effective cancer immunotherapy depends on the robust activation of tumor-specific antigen-presenting cells (APC). Immune agonists encapsulated within nanoparticles (NP) can be delivered to tumor sites to generate powerful antitumor immune responses with minimal off-target dissemination. Systemic delivery enables widespread access to the …

us (code pays fourni par la source)

80 citations Cancer Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.